Menu Search
Equities

Diagnos Inc

ADK:CVE

Diagnos Inc

Actions
TechnologyTechnology
  • Price (CAD)0.355
  • Today's Change0.005 / 1.43%
  • Shares traded13.70k
  • 1 Year change-35.45%
  • Beta-0.4551
Data delayed at least 15 minutes, as of Sep 19 2024 19:13 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CADIncome statement in CADView more

Year on year Diagnos Inc's revenues fell -64.97% from 485.75k to 170.16k. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 2.48m to a larger loss of 3.12m.
Gross margin-460.96%
Net profit margin-1,886.55%
Operating margin-1,555.95%
Return on assets-260.59%
Return on equity--
Return on investment--
More ▼

Cash flow in CADView more

In 2024, cash reserves at Diagnos Inc fell by 77.62k. Cash Flow from Financing totalled 2.08m or 1,224.63% of revenues. In addition the company used 2.15m for operations while cash used for investing totalled 14.02k.
Cash flow per share-0.0397
Price/Cash flow per share--
Book value per share-0.03
Tangible book value per share-0.03
More ▼

Balance sheet in CADView more

Diagnos Inc appears to have a weak balance sheet, highlighted by its negative owner's equity. Additionally, this company's debt load is greater than its assets while day-to-day operations are losing money. Diagnos Inc has considerable financial risk.
Current ratio0.3929
Quick ratio--
Total debt/total equity--
Total debt/total capital4.14
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.